XML 93 R81.htm IDEA: XBRL DOCUMENT
v3.24.3

Subsequent Events (Details) ¥ in Millions, $ in Millions |  | 3 Months Ended
--- | --- | ---
Nov. 05, 2024 USD ($) | Nov. 05, 2024 CNY (¥) | Sep. 30, 2024
Hupan Pharmaceutical (Hubei) Co., Ltd [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Percentage of equity interests | 100.00% | 100.00% |
Hubei Haoyaoshi Zhenghe Pharmacy Chain Co., Ltd [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Percentage of equity interests | 90.00% | 90.00% |
Total consideration of equity interests | $ 0.6 | ¥ 4.0 |
Hubei Huayao Pharmaceutical Co., Ltd [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Percentage of equity interests | 10.00% | 10.00% |
First Installment [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Equity transfer agreement, description |  |  | The first installment of RMB0.8 million (US$0.12 million) will be made in November 2024. As of this report date, the payment has not been made.
Second Installment [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Equity transfer agreement, description |  |  | The second installment of RMB2.4 million (US$0.36 million) shall be paid within 7 working days after the day on which the preconditions for equity transfer as set forth in Article 4 in the Equity Transfer Agreement hereof are fulfilled, and the Transferors confirm and promises in writing to the Transferee.
Third Installment [Member] |  |  |
Subsequent Events [Line Items] |  |  |
Equity transfer agreement, description |  |  | The third installment of RMB0.8 million (US$0.12 million) shall be paid when the transfer is completed that the Parties have gone through all procedures such as company delivery and industrial and commercial registration of changes according to law.

X
- Definition Description of equity transfer agreement. + References No definition available. + Details
Name: | lsh_EquityTransferAgreementDescription
Namespace Prefix: | lsh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date. + References No definition available. + Details
Name: | us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lsh_HupanPharmaceuticalHubeiCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lsh_HubeiHaoyaoshiZhenghePharmacyChainCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lsh_HubeiHuayaoPharmaceuticalCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=lsh_FirstInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=lsh_SecondInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=lsh_ThirdInstallmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |